These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34016462)

  • 21. Nonalcoholic Fatty Liver Disease: Key Considerations Before and After Liver Transplantation.
    Patel YA; Berg CL; Moylan CA
    Dig Dis Sci; 2016 May; 61(5):1406-16. PubMed ID: 26815171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transplant Outcomes in Older Patients With Nonalcoholic Steatohepatitis Compared to Alcohol-related Liver Disease and Hepatitis C.
    Henson JB; Wilder JM; Kappus MR; Barbas AS; Moylan CA; Niedzwiecki D; Muir AJ; Berg CL; Patel YA
    Transplantation; 2020 Jun; 104(6):e164-e173. PubMed ID: 32150036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonalcoholic steatohepatitis in posttransplantation liver: Review article.
    Andrade ARCF; Cotrim HP; Bittencourt PL; Almeida CG; Sorte NCAB
    Rev Assoc Med Bras (1992); 2018 Feb; 64(2):187-194. PubMed ID: 29641680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin blockade does not affect fibrosis progression in recurrent hepatitis C after liver transplantation.
    Guillaud O; Gurram KC; Puglia M; Lilly L; Adeyi O; Renner EL; Selzner N
    Transplant Proc; 2013; 45(6):2331-6. PubMed ID: 23953545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis.
    Castelló B; Aguilera V; Blázquez MT; Rubín Á; García M; Vinaixa C; Benlloch S; SanJuan F; Montalva E; López R; Berenguer M
    Ann Hepatol; 2019; 18(6):855-861. PubMed ID: 31543468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
    Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ
    Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy.
    Flemming JA; Kim WR; Brosgart CL; Terrault NA
    Hepatology; 2017 Mar; 65(3):804-812. PubMed ID: 28012259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-transplant diabetes mellitus and preexisting liver disease - a bidirectional relationship affecting treatment and management.
    Cigrovski Berkovic M; Virovic-Jukic L; Bilic-Curcic I; Mrzljak A
    World J Gastroenterol; 2020 Jun; 26(21):2740-2757. PubMed ID: 32550751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonalcoholic steatohepatitis before and after liver transplant: keeping up with the times.
    Gitto S; Marra F; De Maria N; Bihl F; Villa E; Andreone P; Burra P
    Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):173-178. PubMed ID: 30791778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beyond the NIH Multicenter HIV Transplant Trial Experience: Outcomes of HIV+ Liver Transplant Recipients Compared to HCV+ or HIV+/HCV+ Coinfected Recipients in the United States.
    Sawinski D; Goldberg DS; Blumberg E; Abt PL; Bloom RD; Forde KA
    Clin Infect Dis; 2015 Oct; 61(7):1054-62. PubMed ID: 26082506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of racial/ethnic and etiology/disease-specific factors is associated with lower survival following liver transplantation in African Americans: an analysis from UNOS/OPTN database.
    Wong RJ; Ahmed A
    Clin Transplant; 2014 Jul; 28(7):755-61. PubMed ID: 24750171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocellular Carcinoma in the Setting of Chronic Hepatitis B Virus Infection: Tumor Recurrence and Survival Rates After Liver Transplantation.
    Dugum M; Hanouneh I; Lopez R; Aucejo F; Eghtesad B; Zein N
    Transplant Proc; 2015; 47(6):1939-44. PubMed ID: 26293077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of Nonalcoholic Steatohepatitis After Liver Transplantation: An Updated Meta-Analysis and Systematic Review.
    Yong JN; Lim WH; Ng CH; Tan DJH; Xiao J; Tay PWL; Lin SY; Syn N; Chew N; Nah B; Dan YY; Huang DQ; Tan EXX; Sanyal AJ; Noureddin M; Siddiqui MS; Muthiah MD
    Clin Gastroenterol Hepatol; 2023 Jan; 21(1):45-54.e6. PubMed ID: 34801743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent hepatitis C after retransplantation: factors affecting graft and patient outcome.
    Carmiel-Haggai M; Fiel MI; Gaddipati HC; Abittan C; Hossain S; Roayaie S; Schwartz ME; Gondolesi G; Emre S; Schiano TD
    Liver Transpl; 2005 Dec; 11(12):1567-73. PubMed ID: 16315297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year-community study.
    Allen AM; Therneau TM; Larson JJ; Coward A; Somers VK; Kamath PS
    Hepatology; 2018 May; 67(5):1726-1736. PubMed ID: 28941364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD).
    Golabi P; Otgonsuren M; de Avila L; Sayiner M; Rafiq N; Younossi ZM
    Medicine (Baltimore); 2018 Mar; 97(13):e0214. PubMed ID: 29595666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective Effect of Hepatitis B Against Metabolic Syndrome in Patients with Nonalcoholic Fatty Liver Disease But Not in Normal Individuals.
    Pei C; Wu CZ; Hsieh CH; Chang JB; Liang YJ; Chen YL; Pei D; Lin JD
    Metab Syndr Relat Disord; 2019 Nov; 17(9):458-464. PubMed ID: 31545133
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical, Epidemiological and Histopathological Aspects in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation.
    Tunissiolli NM; Castanhole-Nunes MMU; Pavarino ÉC; da Silva RF; da Silva RCMA; Maria Goloni-Bertollo E
    Asian Pac J Cancer Prev; 2018 Oct; 19(10):2795-2802. PubMed ID: 30360608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonalcoholic Steatohepatitis After Liver Transplantation.
    Cotter TG; Charlton M
    Liver Transpl; 2020 Jan; 26(1):141-159. PubMed ID: 31610081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients.
    Locke JE; Durand C; Reed RD; MacLennan PA; Mehta S; Massie A; Nellore A; DuBay D; Segev DL
    Transplantation; 2016 Jan; 100(1):141-6. PubMed ID: 26177090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.